BACKGROUND: Childhood cancer survivors are at risk for emotional distress symptoms, but symptom comorbidity has not been previously examined. This study examined distress profiles for adult survivors of childhood cancer diagnosed between 1970 and 1999. METHODS: Self-reported depression, anxiety, and somatization symptoms from Brief Symptom Inventory 18 were examined in survivors (n = 16,079) and siblings (n = 3085) from the Childhood Cancer Survivor Study. A latent profile analysis identified clusters of survivors with individual and comorbid symptoms. Disease, treatment, and demographic predictors of distress comorbidity patterns were examined with multinomial logistic regressions. RESULTS: Four clinically relevant profiles were identified: low distress on all subscales (asymptomatic, 62%), high distress on all subscales (comorbid distress, 11%), elevated somatization (somatic symptoms, 13%), and elevated depression and anxiety (affective distress, 14%). Compared with siblings, fewer survivors were asymptomatic (62% vs 74%, P < .0001), and more had comorbid distress (11% vs 5%, P < .0001). Survivors of leukemia (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.12-1.61), central nervous system tumors (OR, 1.30; 95% CI, 1.05-1.61), and sarcoma (OR, 1.26; 95% CI, 1.01-1.57) had a greater risk of comorbid distress than survivors of solid tumors. Psychoactive medications were associated with comorbid distress (P < .0001), and this suggested that this group was refractory to traditional medical management. Comorbid distress was associated with poor perceived health (OR, 31.7; 95% CI, 23.1-43.3), headaches (OR, 3.2; 95% CI, 2.8-3.7), and bodily pain (OR, 4.0; 95% CI, 3.2-5.0). CONCLUSIONS: A significant proportion of survivors are at risk for comorbid distress, which may require extensive treatment approaches beyond those used for individual symptoms. Cancer 2016;122:3215-24.
BACKGROUND:Childhood cancer survivors are at risk for emotional distress symptoms, but symptom comorbidity has not been previously examined. This study examined distress profiles for adult survivors of childhood cancer diagnosed between 1970 and 1999. METHODS: Self-reported depression, anxiety, and somatization symptoms from Brief Symptom Inventory 18 were examined in survivors (n = 16,079) and siblings (n = 3085) from the Childhood Cancer Survivor Study. A latent profile analysis identified clusters of survivors with individual and comorbid symptoms. Disease, treatment, and demographic predictors of distress comorbidity patterns were examined with multinomial logistic regressions. RESULTS: Four clinically relevant profiles were identified: low distress on all subscales (asymptomatic, 62%), high distress on all subscales (comorbid distress, 11%), elevated somatization (somatic symptoms, 13%), and elevated depression and anxiety (affective distress, 14%). Compared with siblings, fewer survivors were asymptomatic (62% vs 74%, P < .0001), and more had comorbid distress (11% vs 5%, P < .0001). Survivors of leukemia (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.12-1.61), central nervous system tumors (OR, 1.30; 95% CI, 1.05-1.61), and sarcoma (OR, 1.26; 95% CI, 1.01-1.57) had a greater risk of comorbid distress than survivors of solid tumors. Psychoactive medications were associated with comorbid distress (P < .0001), and this suggested that this group was refractory to traditional medical management. Comorbid distress was associated with poor perceived health (OR, 31.7; 95% CI, 23.1-43.3), headaches (OR, 3.2; 95% CI, 2.8-3.7), and bodily pain (OR, 4.0; 95% CI, 3.2-5.0). CONCLUSIONS: A significant proportion of survivors are at risk for comorbid distress, which may require extensive treatment approaches beyond those used for individual symptoms. Cancer 2016;122:3215-24.
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Tara M Brinkman; Nan Zhang; Nicole J Ullrich; Pim Brouwers; Daniel M Green; Deo Kumar Srivastava; Lonnie K Zeltzer; Marilyn Stovall; Leslie L Robison; Kevin R Krull Journal: Pediatr Blood Cancer Date: 2012-07-27 Impact factor: 3.167
Authors: Melissa M Hudson; Daniel A Mulrooney; Daniel C Bowers; Charles A Sklar; Daniel M Green; Sarah S Donaldson; Kevin C Oeffinger; Joseph P Neglia; Anna T Meadows; Leslie L Robison Journal: J Clin Oncol Date: 2009-03-16 Impact factor: 44.544
Authors: Micol E Gianinazzi; Corina S Rueegg; Laura Wengenroth; Eva Bergstraesser; Johannes Rischewski; Roland A Ammann; Claudia E Kuehni; Gisela Michel Journal: Psychooncology Date: 2013-02-11 Impact factor: 3.894
Authors: Lonnie K Zeltzer; Qian Lu; Wendy Leisenring; Jennie C I Tsao; Christopher Recklitis; Gregory Armstrong; Ann C Mertens; Leslie L Robison; Kirsten K Ness Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-02 Impact factor: 4.254
Authors: Christopher J Recklitis; Susan K Parsons; Mei-Chiung Shih; Ann Mertens; Leslie L Robison; Lonnie Zeltzer Journal: Psychol Assess Date: 2006-03
Authors: T M Brinkman; L Zhu; L K Zeltzer; C J Recklitis; C Kimberg; N Zhang; A C Muriel; M Stovall; D K Srivastava; L L Robison; K R Krull Journal: Br J Cancer Date: 2013-07-23 Impact factor: 7.640
Authors: Brad J Zebrack; Lonnie K Zeltzer; John Whitton; Ann C Mertens; Lorrie Odom; Roger Berkow; Leslie L Robison Journal: Pediatrics Date: 2002-07 Impact factor: 9.703
Authors: Tara M Brinkman; E Anne Lown; Chenghong Li; Ingrid Tonning Olsson; Jordan Gilleland Marchak; Margaret L Stuber; Stefanie Vuotto; Deokumar Srivastava; Paul C Nathan; Wendy M Leisenring; Gregory T Armstrong; Leslie L Robison; Kevin R Krull Journal: Addiction Date: 2018-10-19 Impact factor: 6.526
Authors: Ronald M Kline; Neeraj K Arora; Cathy J Bradley; Eden R Brauer; Darci L Graves; Natasha Buchanan Lunsford; Mary S McCabe; Shelley Fuld Nasso; Larissa Nekhlyudov; Julia H Rowland; Rebekkah M Schear; Patricia A Ganz Journal: J Natl Cancer Inst Date: 2018-12-01 Impact factor: 13.506
Authors: Tara M Brinkman; Christopher J Recklitis; Gisela Michel; Martha A Grootenhuis; James L Klosky Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Kimberly L Klages; Marie L Chardon; Sarah N Drake; Kasiani C Myers; Caroline F Morrison; Ahna L H Pai Journal: Pediatr Blood Cancer Date: 2022-06-23 Impact factor: 3.838
Authors: Deborah B Crom; Kirsten K Ness; Larry R Martinez; Michelle R Hebl; Leslie L Robison; Melissa M Hudson; Tara M Brinkman Journal: J Cancer Surviv Date: 2018-03-17 Impact factor: 4.442
Authors: I-Chan Huang; Tara M Brinkman; Gregory T Armstrong; Wendy Leisenring; Leslie L Robison; Kevin R Krull Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442
Authors: Fiona S M Schulte; Michaela Patton; Nicole M Alberts; Alicia Kunin-Batson; Barbara A Olson-Bullis; Caitlin Forbes; K Brooke Russell; Alexandra Neville; Lauren C Heathcote; Cynthia W Karlson; Nicole M Racine; Courtney Charnock; Matthew C Hocking; Pia Banerjee; Perri R Tutelman; Melanie Noel; Kevin R Krull Journal: Cancer Date: 2020-10-28 Impact factor: 6.860
Authors: Michael Brinkers; Giselher Pfau; Anne-Marie Toepffer; Frank Meyer; Moritz A Kretzschmar Journal: Pain Res Manag Date: 2021-06-03 Impact factor: 3.037